皮肤病影像市场－全球产业规模、份额、趋势、机会、预测：影像方法、应用、终端用户、区域及竞争格局（2021-2031年）

全球皮肤影像市场预计将从 2025 年的 77.5 亿美元大幅成长至 2031 年的 149.1 亿美元，复合年增长率达到 11.51%。

该领域涵盖皮肤镜检查和光学同调断层扫描(OCT) 等非侵入性技术，这些技术对于诊断过程中皮肤结构的可视化至关重要。市场成长的主要驱动因素包括全球皮肤癌发病率的上升以及早期检测能力的重要性，此外，人口老化和人们对非侵入性诊断方法的日益青睐也推动了这一增长。美国癌症协会估计，到 2025 年，美国将新增 104,960 例侵袭性黑色素瘤病例，进一步凸显了开发可靠诊断解决方案的迫切性。

阻碍市场扩张的主要障碍之一是先进诊断影像设备的高成本。部署高解析度系统所需的大量资本投入限制了其在预算有限的医疗机构中的普及。因此，这种经济负担给发展中地区的小规模诊所和医疗机构带来了阻碍，影响了这些技术的推广，并阻碍了市场的整体成长。

市场驱动因素

人工智慧 (AI) 和机器学习的融合正在从根本上改变全球皮肤影像市场，提高诊断准确率并扩大其可及性。这些技术使基层医疗人员能够以以往只有专科医生才能达到的准确度评估可疑病变，从而满足及时干预的迫切需求。该领域的一个重要里程碑是，首款用于皮肤癌检测的 AI医疗设备获得了 FDA核准。根据 DermaSensor 公司于 2024 年 1 月发布的 FDA 批准公告，该设备在 224 例皮肤癌筛检中达到了 96% 的灵敏度，显着高于标准的基层医疗检测率。这项技术进步可在临床实践中提供即时、客观的结果，简化诊断流程并减少不必要的转诊。

同时，远距皮肤病学和远距离诊断的普及正在突破地域限制，优化医疗流程，从而扩大市场。这一转变对于应对日益严重的全球皮肤病负担至关重要。 2024年，黑色素瘤防治基金会（Aim at Melanoma Foundation）预测，2040年，全球每年新增恶性黑色素瘤病例将达51万例。为了应对如此庞大的病例数量，医疗系统正在利用远端影像技术，有效地优先处理高风险患者。例如，巴茨健康NHS信託泰铢）于2024年4月发布的《远距皮肤病学试点结果》报告显示，在引入新的数位化管道后，疑似皮肤癌患者在就诊两週内确诊的比例提高到94%。这比2022年的平均水准62%有了显着提高，充分体现了远距离诊断工具在皮肤病学服务现代化进程中发挥的关键作用。

市场挑战

先进皮肤影像系统所需的巨额资本投入是限制市场扩张的主要阻碍因素。采用高解析度光学和数位分析技术的设备初始成本极高，难以推广应用，尤其是在开发中国家的小规模私人诊所和医疗机构。这种资金需求构成了进入门槛，阻碍了这些诊断工具在各种医疗机构中的广泛应用。当医疗专业人员必须承担高昂的购买成本而无法即时获得收益保证时，这些设备的普及应用就会被显着延缓，直接影响全球市场的成长轨迹。

营运成本和报销率的降低使得投资昂贵的影像设备变得更加困难。据美国医学会 (AMA) 称，2024 年联邦医疗保险 (Medicare) 医生报销额度削减 1.25% 将进一步给医疗机构带来财务压力。这种紧缩政策将限制用于升级诊断基础设施的预算，导致许多皮肤科医生推迟或放弃购买先进的影像设备。这种经济环境正在缩小製造商的潜在基本客群，并阻碍市场充分发挥商业性潜力。

市场趋势

3D全身影像技术的广泛应用正在革新黑色素瘤监测方式，使其从单一病灶评估转向全身影像。这些系统利用高解析度相机阵列，产生患者的数位双胞胎，使临床医生能够以前所未有的精度监测痣的进展并检测细微变化。这种自动化流程规范了高风险患者的记录，并有助于进行高效的时间序列监测。 Canfield Scientific公司2024年7月发布的公告「ACEMID获得津贴，在Mildura Base公立医院部署VECTRA WB360系统，扩大网路覆盖范围」充分体现了这项技术的部署规模。该公告指出，澳洲黑色素瘤成像卓越中心（ACEMID）已将其用于皮肤癌筛检的VECTRA WB360系统网路扩展至16个地点。

同时，影像技术正渗透到美容皮肤科领域，为客观的皮肤分析和治疗模拟提供支援。诊断工具的改进使其能够可视化皮肤类型和日晒损伤等指标，从而帮助医疗专业人员量化老化征兆并检验美容疗程的效果。影像诊断设备能够提供可视化证据，使其在患者咨询中不可或缺，有效弥合了患者期望与临床实际情况之间的差距。这一趋势在行业评估中也得到了印证。根据 QuantifiCare 公司 2024 年 3 月发布的公告“LifeViz Mini Pro 荣获 2024 年度最佳美容设备奖”，该公司的 3D 成像诊断产品线第五次荣获该奖项，再次印证了该领域对专业视觉化系统的高度依赖。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球皮肤影像市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 诊断影像方法（数位摄影影像、皮肤镜检查等）
  • 适用范围（色素性病变、干癣、皮肤癌、整形/重组手术等）
  • 依最终使用者（医院、专科诊所、皮肤修復中心）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美皮肤影像市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲皮肤影像市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区皮肤影像市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲皮肤影像市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲皮肤影像市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球皮肤病影像市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Navitar Inc.
• E-Control Systems Inc.
• Caliberid Imaging & Diagnostics Inc.
• Emage Medical LLC
• Courage+Khazaka electronic GmbH
• Atys Medical SAS
• Longport Inc.
• Cortex Technology ApS
• Canfield Scientific Inc.
• Taberna Pro Medicum GmbH

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Dermatology Imaging Market is projected to experience substantial growth, rising from a valuation of USD 7.75 Billion in 2025 to USD 14.91 Billion by 2031, achieving a CAGR of 11.51%. This sector encompasses noninvasive technologies, such as dermatoscopy and optical coherence tomography, which are essential for visualizing skin structures during diagnosis. The market's momentum is primarily fueled by the increasing global incidence of skin cancers and the critical necessity for early detection capabilities, trends that are reinforced by an aging demographic and a growing preference for noninvasive diagnostic methods. Underscoring this urgency, the American Cancer Society estimates that 104,960 new cases of invasive melanoma will be diagnosed in the United States in 2025, highlighting the imperative for robust diagnostic solutions.

One major obstacle hindering market expansion is the substantial cost associated with advanced imaging equipment. The significant capital investment required to acquire high-resolution systems limits their availability in healthcare environments with restricted budgets. Consequently, this financial strain on smaller clinics and facilities in developing regions curtails the widespread adoption of these technologies and impedes the overall growth trajectory of the market.

Market Driver

The incorporation of Artificial Intelligence and Machine Learning is fundamentally transforming the Global Dermatology Imaging Market by elevating diagnostic precision and broadening accessibility. These technologies empower primary care providers to assess suspicious lesions with a degree of accuracy formerly exclusive to specialists, thereby addressing the vital need for timely intervention. A major milestone in this field was reached when the FDA cleared the first AI-enabled medical device designed for skin cancer detection. As reported by DermaSensor Inc. in their January 2024 'FDA Clearance Announcement,' the device achieved a sensitivity of 96 percent across 224 tested skin cancers, significantly surpassing standard primary care detection rates. This technological advancement permits immediate, objective results at the point of care, effectively streamlining the diagnostic workflow and reducing the frequency of unnecessary referrals.

Concurrently, the increasing use of teledermatology and remote diagnostics is extending market reach by overcoming geographical limitations and optimizing healthcare processes. This shift is crucial for managing the escalating global burden of skin conditions; the Aim at Melanoma Foundation noted in 2024 that annual new melanoma diagnoses worldwide are expected to rise to 510,000 by 2040. To handle such volumes, healthcare systems are utilizing remote imaging to prioritize high-risk patients efficiently. For instance, Barts Health NHS Trust reported in their April 2024 'Teledermatology Pilot Results' that the implementation of a new digital pathway improved the proportion of suspected skin cancer patients seen within two weeks to 94 percent, a significant increase from the 62 percent average in 2022, demonstrating the essential role of remote diagnostic tools in modernizing dermatology services.

Market Challenge

The significant capital investment necessary for advanced dermatology imaging systems constitutes a primary restraint on market expansion. Technologies utilizing high-resolution optics and digital analysis entail substantial upfront costs that restrict their accessibility, particularly for smaller private clinics and healthcare facilities in developing nations. This financial requirement creates a barrier to entry, preventing the widespread adoption of these diagnostic tools across various healthcare settings. When practitioners face high acquisition costs without the assurance of immediate financial returns, the uptake of these devices slows considerably, directly affecting the overall growth trajectory of the global market.

Operational expenditures and declining reimbursement rates further exacerbate the difficulty of investing in expensive imaging capital. According to the American Medical Association, the Medicare physician payment schedule was reduced by 1.25 percent in 2024, placing additional financial pressure on medical practices. This fiscal tightening limits the budget available for upgrading diagnostic infrastructure, compelling many dermatologists to postpone or forego the purchase of advanced imaging units. This economic environment restricts the potential customer base for manufacturers and hinders the market's ability to realize its full commercial potential.

Market Trends

The increasing utilization of 3D total body photography is revolutionizing melanoma surveillance by shifting the focus from individual lesion assessment to comprehensive whole-body mapping. These systems employ high-resolution camera arrays to generate a digital twin of the patient, enabling clinicians to monitor the evolution of moles and detect subtle changes with unprecedented accuracy. This automation standardizes documentation for high-risk patients, facilitating efficient longitudinal monitoring. The scale of such adoption is illustrated by Canfield Scientific's July 2024 announcement regarding the 'ACEMID Expands Network with Grant to Install VECTRA WB360 at Mildura Base Public Hospital,' which noted that the Australian Centre of Excellence in Melanoma Imaging & Diagnosis has successfully grown to include a 16th site using the VECTRA WB360 system for skin cancer screening.

Simultaneously, imaging technologies are penetrating the field of aesthetic dermatology to support objective skin analysis and treatment simulation. Diagnostic tools are being adapted to visualize metrics like texture and sun damage, allowing practitioners to quantify signs of aging and validate cosmetic treatments. The ability to provide visual evidence has made imaging units essential for patient consultations, effectively bridging the gap between patient expectations and clinical realities. This trend is highlighted by industry recognition; according to QuantifiCare's March 2024 'LifeViz Mini Pro Awarded Best Aesthetic Device 2024' announcement, their 3D imaging range received the Best Aesthetic Device award for the fifth time, confirming the sector's strong reliance on specialized visualization systems.

Key Market Players

• Navitar Inc.
• E-Control Systems Inc.
• Caliberid Imaging & Diagnostics Inc.
• Emage Medical LLC
• Courage + Khazaka electronic GmbH
• Atys Medical SAS
• Longport Inc.
• Cortex Technology ApS
• Canfield Scientific Inc.
• Taberna Pro Medicum GmbH

Report Scope

In this report, the Global Dermatology Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermatology Imaging Market, By Imaging Modality

• Digital Photographic Imaging
• Dermoscopy
• Others

Dermatology Imaging Market, By Application

• Pigmented Lesions
• Psoriasis
• Skin Cancer
• Plastic and Reconstructive Surgery
• Others

Dermatology Imaging Market, By End User

• Hospitals
• Specialty Clinics
• Skin Rejuvenation Centers

Dermatology Imaging Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermatology Imaging Market.

Available Customizations:

Global Dermatology Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermatology Imaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Imaging Modality (Digital Photographic Imaging, Dermoscopy, Others)
  • 5.2.2. By Application (Pigmented Lesions, Psoriasis, Skin Cancer, Plastic and Reconstructive Surgery, Others)
  • 5.2.3. By End User (Hospitals, Specialty Clinics, Skin Rejuvenation Centers)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Dermatology Imaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Imaging Modality
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dermatology Imaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Imaging Modality
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Dermatology Imaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Imaging Modality
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Dermatology Imaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Imaging Modality
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Dermatology Imaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Imaging Modality
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dermatology Imaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Imaging Modality
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Dermatology Imaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Imaging Modality
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Dermatology Imaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Imaging Modality
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Dermatology Imaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Imaging Modality
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Dermatology Imaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Imaging Modality
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Dermatology Imaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Imaging Modality
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dermatology Imaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Imaging Modality
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Dermatology Imaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Imaging Modality
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Dermatology Imaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Imaging Modality
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Dermatology Imaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Imaging Modality
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Dermatology Imaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Imaging Modality
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Dermatology Imaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Imaging Modality
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dermatology Imaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Imaging Modality
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Dermatology Imaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Imaging Modality
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Dermatology Imaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Imaging Modality
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Dermatology Imaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Imaging Modality
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dermatology Imaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Imaging Modality
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Dermatology Imaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Imaging Modality
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Dermatology Imaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Imaging Modality
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dermatology Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Navitar Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. E-Control Systems Inc.
• 15.3. Caliberid Imaging & Diagnostics Inc.
• 15.4. Emage Medical LLC
• 15.5. Courage + Khazaka electronic GmbH
• 15.6. Atys Medical SAS
• 15.7. Longport Inc.
• 15.8. Cortex Technology ApS
• 15.9. Canfield Scientific Inc.
• 15.10. Taberna Pro Medicum GmbH

16. Strategic Recommendations

17. About Us & Disclaimer